Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Strand Therapeutics has raised $153.0M in total funding. The most recent round was Series B. The last funding was announced in August 2025.
Strand Therapeutics's investors include Playground Global, ANRI, JIC Venture Growth Investments, Redmile Group, FPV Ventures.
Strand Therapeutics is headquartered in Cambridge, United States.
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Strand Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Strand Therapeutics — Funding & Investors." VCBacked, August 3, 2025, https://www.vcbacked.co/company/strand-therapeutics. Accessed July 21, 2026.
VCBacked. (2025). Strand Therapeutics — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/strand-therapeutics
{{cite web |title=Strand Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/strand-therapeutics |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated